Protagonist Therapeutics, Inc

Skandinaviska Enskilda Banken AB (publ) PTGX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

205,574

Value ($000)

17,955

Weight

0.1%

2021 Q2 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	17,955	0.1%	205,574	12/31/2025
2025 Q3	11/7/2025	5,234	0.0%	78,796	9/30/2025
2025 Q2	8/13/2025	4,574	0.0%	82,750	6/30/2025
2025 Q1	5/7/2025	12,039	0.1%	248,950	3/31/2025
2024 Q4	2/10/2025	11,963	0.1%	310,650	12/31/2024
2024 Q3	11/7/2024	10,355	0.0%	230,114	9/30/2024
2024 Q2	8/13/2024	655	0.0%	18,914	6/30/2024
2024 Q1	5/13/2024	547	0.0%	18,914	3/31/2024
2023 Q4	2/14/2024	434	0.0%	18,914	12/31/2023
2023 Q3	11/9/2023	315	0.0%	18,914	9/30/2023
2023 Q2	8/7/2023	522	0.0%	18,914	6/30/2023
2022 Q3	11/14/2022	413	0.0%	48,977	9/30/2022
2022 Q2	8/10/2022	387	0.0%	48,977	6/30/2022
2022 Q1	5/11/2022	1,160	0.0%	48,977	3/31/2022
2021 Q4	2/10/2022	1,312	0.0%	38,304	12/31/2021
2021 Q3	11/10/2021	679	0.0%	38,304	9/30/2021
2021 Q2	8/10/2021	1,375	0.0%	30,628	6/30/2021